|
(+)-Pseudoephedrine Hydrochloride DRUG PRECURSOR
|
LGCFOR2115.00
|
|
(-)-Cannabidiol
|
LGCFOR1088.02
|
|
(1S,2R)-(+)-Ephedrine Hydrochloride DRUG PRECURSOR
|
LGCFOR0652.03
|
|
(2-Chlorophenyl)diphenylmethanol
|
LGCFOR0015.01
|
|
1-(2-Methoxyphenyl)piperazine Dihydrochloride
|
LGCFOR1247.02
|
|
1-(Thiophen-2-yl)-2-methylaminopropane Hydrochloride (Methiopropamine Hydrochloride, MPA HCl)
|
LGCFOR1275.59
|
|
1-Methyl-3-phenylpiperazine
|
LGCFOR1005.07
|
|
1-Methyl-4-(phenylmethyl)piperazine Hydrochloride
|
LGCFOR1280.01
|
|
1-Methylamino-1-(3,4-methylenedioxyphenyl)propane Hydrochloride
|
LGCFOR1275.41
|
|
1-Naphyrone Hydrochloride (1-Naphthalen-1-yl-2-pyrrolidin-1-ylpentan-1-one Hydrochloride)
|
LGCFOR1275.35
|
|
1-Piperonylpiperazine
|
LGCFOR1275.46
|
|
1-[(4-Chlorophenyl)phenylmethyl]piperazine
|
LGCFOR0380.01
|
|
10-Hydroxy-10,11-dihydrocarbamazepine
|
LGCFOR0076.10
|
|
10-Hydroxyamitriptyline
|
LGCFOR0062.05
|
|
10-Hydroxyimipramine BH3-Aduct
|
LGCFOR0077.04
|
|
11-Deoxycortisol (17,21-Dihydroxypregn-4-ene-3,20-dione)
|
LGCFOR0185.08
|
|
16alpha-Hydroxyprednisolone (11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione)
|
LGCFOR0204.01
|
|
2-Amino-2',5-dichlorobenzophenone
|
LGCFOR0071.01
|
|
2-Amino-5-chlorobenzophenone
|
LGCFOR0028.03
|
|
2-Amino-5-nitrobenzophenone
|
LGCFOR0078.01
|
